HKU Scholars Hub: Browsing DSpace

Browsing by Author Alves, K

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 9 of 9

	Title	Author(s)	Issue Date	Views
	Analysis of longer-term safety profile of the hepatitis B virus core inhibitor ABI-H0731 in an open label extension study Proceeding/Conference:Hepatology	Jacobson, IM Ma, X Nguyen, T Schiff, ER Yuen, RMF Hann, HWL Sulkowski, MS Nahass, RG Ramji, A Agarwal, K Park, JS Ayoub, WS Gane, EJ Knox, S Alves, K Li, YF Stamm, LM Weilert, F Bennett, M Han, SHB Ravendhran, N Chan, S Kwo, PY Elkhashab, M Hassanein, T Fung, SK Bae, H Lalezari, JP Dieterick, DT	2020	12
	Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Fung, S Sulkowski, M Lalezari, J Schiff, ER Dieterich, D Hassanein, T Kwo, P Elkhashab, M Nahass, R Ayoub, W Han, SH Bonacini, M Alves, K Zayed, H Huang, Q Colonno, R Knox, S Ramji, A Bennett, M Gane, E Ravendhran, N Park, J Jacobson, I Bae, H Chan, S Hann, HW Ma, X Nguyen, T Yuen, RMF	2020
	Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study Proceeding/Conference:Journal of Hepatology	Yuen, RMF Agarwal, K Ma, X Nguyen, T Schiff, ER Hann, HW Dieterich, D Nahass, R Park, J Chan, S Han, SH Gane, E Bennett, M Alves, K Zayed, H Huang, Q Colonno, R Knox, S Stamm, L Bonacini, M Jacobson, I Ayoub, W Weilert, F Ravendhran, N Ramji, A Kwo, P Elkhashab, M Hassanein, T Bae, H Lalezari, J Fung, S Sulkowski, M	2020	40
	Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Agarwal, K Niu, J Ding, Y Gane, E Nguyen, T Alves, K Evanchick, M Zayed, H Huang, Q Knox, S Stamm, L Colonno, R Hassanein, T Kim, DJ Lim, YS Yuen, RMF	2020
	Continued therapy with ABI-H0731+NRTI results in sequential reduction/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg positive patients Proceeding/Conference:Hepatology	Sulkowski, MS Agarwal, K Fung, SK Yuen, RMF Ma, XL Lalezari, JP Nguyen, TT Bae, HS Schiff, ER Hassanein, T Hann, HWL Elkhashab, M Dieterich, DT Kwo, PY Nahass, R Ramji, A Park, JS Ravendhran, N Chan, S Weilert, F Han, SHB Ayoub, WS Gane, EJ Jacobson, IM Bennett, M Bonacini, M Zayed, H Alves, K Huey, V Huang, Q Ruby, E Qiang, DM Knox, S Colonno, R	2019	53
	Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection Journal:Journal of Hepatology	Sulkowski, MS Agarwal, K Ma, XL Nguyen, TT Schiff, ER Hann, H-W L Dieterich, DT Nahass, RG Park, JS Chan, S Han, S-H B Gane, EJ Bennett, M Alves, K Evanchik, M Yan, R Huang, Q Lopatin, U Colonno, R Ma, J Knox, SJ Stamm, LM Bonacini, M Jacobson, IM Ayoub, WS Weilert, F Ravendhran, N Ramj, A Kwo, PY Elkhashab, M Hassanein, T Bae, HS Lalezari, JP Fung, SK Yuen, RMF	2022
	Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection Journal:Journal of Hepatology	Yuen, RMF Agarwal, K Ma, XL Nguyen, TT Schiff, ER Hann, H-WL Dieterich, DT Nahass, RT Park, JS Chan, S Han, S-H B Gane, EJ Bennett, M Alves, K Evanchik, M Yan, R Huang, Q Lopatin, U Colonno, R Ma, J Knox, SJ Stamm, LM Bonacini, M Jacobson, IM Ayoub, WS Weilert, F Ravendhran, N Ramji, A Kwo, PY Elkhashab, M Hassanein, T Bae, HS Lalezari, JP Fung, SK Sulkowski, MS	2022
	Safety, pharmacokinetics and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: A randomized, placebo-controlled phase 1 study Journal:Journal of Viral Hepatitis	Agarwal, K Xu, J Gane, EJ Nguyen, TT Ding, YH Knox, SJ Alves, K Evanchik, M Zomorodi, K Ma, JL Yan, R Huang, Q Colonno, R Stamm, LM Hassanein, TI Kim, DJ Lim, YS Yuen, MF	12-Jan-2023
	The second-generation hepatitis B virus (HBV) core inhibitor (CI) ABI-H2158 is associated with potent antiviral activity in a 14-day monotherapy study in HBeAg-positive patients with chronic hepatitis B (CHB) Proceeding/Conference:Hepatology	Yuen, RMF Agarwal, K Gane, EJ Nguyen, TT Hassanein, T Kim, DJ Alves, K Zayed, H Qiang, DM Ruby, E Evanchik, M Huang, Q Knox, S Colonno, R on behalf of ABI-H2158 Study Team	2019	29

Showing results 1 to 9 of 9